Skip to main content
. 2022 Aug 24;3:925834. doi: 10.3389/fpain.2022.925834

Table 1.

VHA and national prevalence of IC/BPS.

Strict Criteria Equivocal Criteria
Prevalence Rate* 95% CI Rate 95% CI
Overall** 0.30 (0.00, 0.72) 0.33 (0.00, 0.82)
Male 0.23 (0.00, 0.63) 0.24 (0.00, 0.73)
    <40yr 1.64 (0.00, 0.63) 1.64 (0.00, 0.73)
   40–49yr 0.03 (0.00, 2.86) 0.03 (0.00, 2.87)
   50–59yr 0.02 (0.00, 0.22) 0.03 (0.00, 0.29)
   60–69yr 0.07 (0.00, 0.18) 0.08 (0.00, 0.28)
   70+ 0.05 (0.00, 0.53) 0.08 (0.00, 0.60)
Female 1.11 (0.00, 5.09) 1.23 (0.00, 6.06)
    <40yr 1.62 (0.00, 7.04) 1.69 (0.00, 7.62)
   40–49yr 0.89 (0.00, 6.23) 1.08 (0.00, 7.67)
   50–59yr 1.43 (0.00, 4.66) 1.59 (0.00, 5.63)
   60–69yr 0.36 (0.00, 2.94) 0.48 (0.00, 3.92)
   70+ 0.13 (0.00, 1.12) 0.22 (0.00, 1.87)

VHA; Veterans Health Affairs, IC/BPS; interstitial cystitis/bladder pain syndrome.

*Rate per 100 persons.

**By strict criteria, overall US Standardized rate was 0.87 (95% CI: 0.32,1.42) overall, 0.66 (95% CI: 0.44, 0.87) for men and 1.08 (95% CI: 0.03, 2.13) for women. By Equivocal criteria, overall US Standardized rate was 0.94 (95% CI: 0.32,1.56) overall, 0.67 (95% CI: 0.58, 0.75) for men and 1.20 (95% CI: 0.00, 2.39) for women.